Genesem Inc. (KOSDAQ:217190)
South Korea
· Delayed Price · Currency is KRW 5,040.00
-50.00 (-0.98%)
At close: Dec 5, 2025
Genesem Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Operating Revenue | 57,758 | 68,738 | 56,454 | 59,603 | 59,727 | 41,942 |
| Other Revenue | - | -0 | - | - | - | - |
| Revenue | 57,758 | 68,738 | 56,454 | 59,603 | 59,727 | 41,942 |
| Revenue Growth (YoY) | -17.70% | 21.76% | -5.28% | -0.21% | 42.41% | - |
| Cost of Revenue | 37,104 | 39,752 | 36,627 | 35,601 | 39,109 | 30,204 |
| Gross Profit | 20,653 | 28,986 | 19,827 | 24,002 | 20,619 | 11,738 |
| Selling, General & Admin | 12,161 | 14,790 | 10,573 | 10,160 | 10,280 | 8,183 |
| Research & Development | 5,664 | 5,693 | 4,385 | 4,161 | 3,583 | 2,975 |
| Amortization of Goodwill & Intangibles | 117.61 | 125.69 | 109.25 | 95.02 | 116.68 | 98.43 |
| Other Operating Expenses | 282.86 | 266.44 | 272.35 | 259.36 | 287.43 | 292.4 |
| Operating Expenses | 18,474 | 22,445 | 16,265 | 15,484 | 14,985 | 12,782 |
| Operating Income | 2,179 | 6,541 | 3,562 | 8,519 | 5,633 | -1,044 |
| Interest Expense | -741.59 | -879.04 | -876.24 | -665.08 | -540.98 | -490.43 |
| Interest & Investment Income | 374.93 | 401.21 | 320.22 | 157.35 | 18.89 | 17.17 |
| Currency Exchange Gain (Loss) | 472.4 | 1,119 | 85.02 | 473.2 | 349.11 | -114.73 |
| Other Non Operating Income (Expenses) | 99.39 | 3.85 | -7.44 | -103.38 | -139.39 | 524.93 |
| EBT Excluding Unusual Items | 2,385 | 7,187 | 3,083 | 8,381 | 5,321 | -1,108 |
| Gain (Loss) on Sale of Investments | 37.95 | 23.1 | 30.38 | 17.23 | 11.55 | 6.38 |
| Gain (Loss) on Sale of Assets | 18.9 | -17.85 | - | - | 0.77 | 37.43 |
| Asset Writedown | - | - | - | -15 | - | -64.39 |
| Pretax Income | 2,441 | 7,192 | 3,114 | 8,383 | 5,333 | -1,128 |
| Income Tax Expense | 194.91 | 1,071 | -482.29 | -3,807 | 90.66 | -69.6 |
| Earnings From Continuing Operations | 2,247 | 6,121 | 3,596 | 12,190 | 5,242 | -1,059 |
| Minority Interest in Earnings | 1.23 | -36.91 | 129.32 | 43.22 | 0.13 | - |
| Net Income | 2,248 | 6,084 | 3,725 | 12,233 | 5,243 | -1,059 |
| Net Income to Common | 2,248 | 6,084 | 3,725 | 12,233 | 5,243 | -1,059 |
| Net Income Growth | -67.05% | 63.31% | -69.55% | 133.34% | - | - |
| Shares Outstanding (Basic) | 13 | 13 | 13 | 13 | 13 | 13 |
| Shares Outstanding (Diluted) | 13 | 13 | 13 | 13 | 13 | 13 |
| EPS (Basic) | 170.89 | 462.53 | 283.22 | 930.00 | 398.56 | -80.47 |
| EPS (Diluted) | 170.89 | 462.53 | 283.22 | 930.00 | 398.56 | -80.47 |
| EPS Growth | -67.05% | 63.31% | -69.55% | 133.34% | - | - |
| Free Cash Flow | 3,581 | 8,578 | 2,759 | 8,250 | 3,577 | -4,569 |
| Free Cash Flow Per Share | 272.27 | 652.15 | 209.77 | 627.16 | 271.90 | -347.33 |
| Dividend Per Share | 50.000 | 50.000 | - | - | - | - |
| Gross Margin | 35.76% | 42.17% | 35.12% | 40.27% | 34.52% | 27.98% |
| Operating Margin | 3.77% | 9.52% | 6.31% | 14.29% | 9.43% | -2.49% |
| Profit Margin | 3.89% | 8.85% | 6.60% | 20.52% | 8.78% | -2.52% |
| Free Cash Flow Margin | 6.20% | 12.48% | 4.89% | 13.84% | 5.99% | -10.89% |
| EBITDA | 3,374 | 7,835 | 4,779 | 9,715 | 6,828 | 48.31 |
| EBITDA Margin | 5.84% | 11.40% | 8.46% | 16.30% | 11.43% | 0.11% |
| D&A For EBITDA | 1,195 | 1,293 | 1,217 | 1,196 | 1,195 | 1,093 |
| EBIT | 2,179 | 6,541 | 3,562 | 8,519 | 5,633 | -1,044 |
| EBIT Margin | 3.77% | 9.52% | 6.31% | 14.29% | 9.43% | -2.49% |
| Effective Tax Rate | 7.98% | 14.89% | - | - | 1.70% | - |
| Advertising Expenses | - | 206.01 | 68.25 | 64.28 | 14.84 | 6 |
Source: S&P Capital IQ. Standard template. Financial Sources.